Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Activating PKM2 and Wnt/β-catenin signaling together can potentially enhance hair growth and could be a treatment for hair loss.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.